Jan Lünemann
Hat mitgewirkt an:
-
Target analysis of underivatized biogenic amines with reversed-phase chromatography and quadrupole time-of-flight mass spectrometry
-
Synthetic Cell-Based Immunotherapies for Neurologic Diseases
-
Profiling Complement System Components in Primary CNS Vasculitis
-
Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis